Chromatography-free synthesis of Corey's intermediate for Tamiflu
摘要:
Column chromatography-free stereoselective synthesis of Corey's intermediate for Tamiflu (oseltamivir phosphate) was achieved, starting from L-glutamic acid gamma-ethyl ester. The reagents and solvents used in the reaction scheme are industrially tractable, rendering the synthesis a potential starting point for process research. (C) 2014 Elsevier Ltd. All rights reserved.
Chromatography-free synthesis of Corey's intermediate for Tamiflu
摘要:
Column chromatography-free stereoselective synthesis of Corey's intermediate for Tamiflu (oseltamivir phosphate) was achieved, starting from L-glutamic acid gamma-ethyl ester. The reagents and solvents used in the reaction scheme are industrially tractable, rendering the synthesis a potential starting point for process research. (C) 2014 Elsevier Ltd. All rights reserved.
The present invention relates to modulators of metalloproteinase activity.
本发明涉及金属蛋白酶活性调节剂。
GLUTAMATE AGGRECANASE INHIBITORS
申请人:Sum Phaik-Eng
公开号:US20100010012A1
公开(公告)日:2010-01-14
The present invention relates to modulators of metalloproteinase activity.
本发明涉及金属蛋白酶活性调节剂。
Two Approaches toward the Formal Total Synthesis of Oseltamivir Phosphate (Tamiflu): Catalytic Enantioselective Three-Component Reaction Strategy and <scp>l</scp>-Glutamic Acid Strategy
Two independent formal total syntheses of oseltamivir phosphate were successfully achieved: the first utilized a copper-catalyzed asymmetric three-component reaction strategy, and the second utilized L-glutamic acid gamma-ester as a chiral source to install the correct stereochemistry. Both strategies used Dieckmann condensation to construct a six-membered ring core, after which manipulation of the functional groups and protecting groups accessed Corey's intermediate for the synthesis of oseltamivir phosphate. While the first synthesis was accomplished via four purification steps in 25.7% overall yield, albeit with moderate optical purity (76% ee), the second strategy achieved the synthesis via six purification steps in 19.8% overall yield with perfect enantiocontrol.